Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.AnaSpec establishes new headquarters in Fremont, California
According to AnaSpec, the 44,010 square foot facility offers all top of the line lab/R&D equipment and services. All divisions will be housed under one roof for increased
According to AnaSpec, the 44,010 square foot facility offers all top of the line lab/R&D equipment and services. All divisions will be housed under one roof for increased
Under the Prescription Drug User Fee Act, the FDA is expected to take action on the application by August 28, 2009. Armando Anido, CEO and president of Auxilium,
Under the terms of the joint development agreement, Mast will have exclusive rights to develop specified products and negotiate commercialization terms for such products for a period of
As part of the collaboration, Isis has co-exclusively licensed its single-stranded RNAi (ssRNAi) technology to Alnylam in exchange for upfront payments, R&D milestone payments, and royalties. The alliance
Mr Brenkert has served as CFO of the company since January 2003. Succeeding Mr Brenkert as senior vice president and CFO is Keith Cheesman, vice president of accounting
Aperio’s VQ technology enables content-based image retrieval to allow pathologists and researchers to search libraries of digital slides using image data, and to efficiently retrieve similar images from
The Ministry of Public Health (MOH) order is supported by Sinovac’s newly completed filling and packaging plant that has increased Sinovac’s annual capacity to 20 million doses. Sinovac
The organizations are combining forces to offer the life-science industry’s first jointly offered genomic analysis cloud-computing solution, which is an approach to computing in which scalable and often
The company has proceeded with grant formalities and validation of the patents. Corresponding patents and applications have issued or are pending worldwide. Together, the patents will provide protection
The patents cover composition and methods to target the Ebola virus VP35 protein with a range of PMOplus compounds. The patents have an expiration date of October 31,